1 Insulin API Market Overview 1.1 Product Overview and Scope of Insulin API 1.2 Insulin API Segment by Type 1.2.1 Global Insulin API Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Regular Human Insulin 1.2.3 Insulin Analogue 1.3 Insulin API Segment by Application 1.3.1 Insulin API Sales Comparison by Application: (2021-2027) 1.3.2 Fast-Acting 1.3.3 Premix 1.3.4 Long-Acting 1.4 Global Insulin API Market Size Estimates and Forecasts 1.4.1 Global Insulin API Revenue 2016-2027 1.4.2 Global Insulin API Sales 2016-2027 1.4.3 Insulin API Market Size by Region: 2016 Versus 2021 Versus 2027 2 Insulin API Market Competition by Manufacturers 2.1 Global Insulin API Sales Market Share by Manufacturers (2016-2021) 2.2 Global Insulin API Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Insulin API Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Insulin API Manufacturing Sites, Area Served, Product Type 2.5 Insulin API Market Competitive Situation and Trends 2.5.1 Insulin API Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Insulin API Players Market Share by Revenue 2.5.3 Global Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Insulin API Retrospective Market Scenario by Region 3.1 Global Insulin API Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Insulin API Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Insulin API Market Facts & Figures by Country 3.3.1 North America Insulin API Sales by Country 3.3.2 North America Insulin API Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Insulin API Market Facts & Figures by Country 3.4.1 Europe Insulin API Sales by Country 3.4.2 Europe Insulin API Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Insulin API Market Facts & Figures by Region 3.5.1 Asia Pacific Insulin API Sales by Region 3.5.2 Asia Pacific Insulin API Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Insulin API Market Facts & Figures by Country 3.6.1 Latin America Insulin API Sales by Country 3.6.2 Latin America Insulin API Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Insulin API Market Facts & Figures by Country 3.7.1 Middle East and Africa Insulin API Sales by Country 3.7.2 Middle East and Africa Insulin API Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Insulin API Historic Market Analysis by Type 4.1 Global Insulin API Sales Market Share by Type (2016-2021) 4.2 Global Insulin API Revenue Market Share by Type (2016-2021) 4.3 Global Insulin API Price by Type (2016-2021) 5 Global Insulin API Historic Market Analysis by Application 5.1 Global Insulin API Sales Market Share by Application (2016-2021) 5.2 Global Insulin API Revenue Market Share by Application (2016-2021) 5.3 Global Insulin API Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Novo Nordisk 6.1.1 Novo Nordisk Corporation Information 6.1.2 Novo Nordisk Description and Business Overview 6.1.3 Novo Nordisk Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Novo Nordisk Product Portfolio 6.1.5 Novo Nordisk Recent Developments/Updates 6.2 Sanofi-Aventis 6.2.1 Sanofi-Aventis Corporation Information 6.2.2 Sanofi-Aventis Description and Business Overview 6.2.3 Sanofi-Aventis Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Sanofi-Aventis Product Portfolio 6.2.5 Sanofi-Aventis Recent Developments/Updates 6.3 Eli Lilly 6.3.1 Eli Lilly Corporation Information 6.3.2 Eli Lilly Description and Business Overview 6.3.3 Eli Lilly Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Eli Lilly Product Portfolio 6.3.5 Eli Lilly Recent Developments/Updates 6.4 Tonghua Dongbao 6.4.1 Tonghua Dongbao Corporation Information 6.4.2 Tonghua Dongbao Description and Business Overview 6.4.3 Tonghua Dongbao Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Tonghua Dongbao Product Portfolio 6.4.5 Tonghua Dongbao Recent Developments/Updates 6.5 Ganlee 6.5.1 Ganlee Corporation Information 6.5.2 Ganlee Description and Business Overview 6.5.3 Ganlee Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Ganlee Product Portfolio 6.5.5 Ganlee Recent Developments/Updates 6.6 United Laboratory 6.6.1 United Laboratory Corporation Information 6.6.2 United Laboratory Description and Business Overview 6.6.3 United Laboratory Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.6.4 United Laboratory Product Portfolio 6.6.5 United Laboratory Recent Developments/Updates 6.7 Biocon 6.6.1 Biocon Corporation Information 6.6.2 Biocon Description and Business Overview 6.6.3 Biocon Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Biocon Product Portfolio 6.7.5 Biocon Recent Developments/Updates 6.8 Amphastar 6.8.1 Amphastar Corporation Information 6.8.2 Amphastar Description and Business Overview 6.8.3 Amphastar Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Amphastar Product Portfolio 6.8.5 Amphastar Recent Developments/Updates 6.9 Wockhardt 6.9.1 Wockhardt Corporation Information 6.9.2 Wockhardt Description and Business Overview 6.9.3 Wockhardt Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Wockhardt Product Portfolio 6.9.5 Wockhardt Recent Developments/Updates 6.10 Julphar Diabetes 6.10.1 Julphar Diabetes Corporation Information 6.10.2 Julphar Diabetes Description and Business Overview 6.10.3 Julphar Diabetes Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Julphar Diabetes Product Portfolio 6.10.5 Julphar Diabetes Recent Developments/Updates 6.11 Torrent Pharma 6.11.1 Torrent Pharma Corporation Information 6.11.2 Torrent Pharma Insulin API Description and Business Overview 6.11.3 Torrent Pharma Insulin API Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Torrent Pharma Product Portfolio 6.11.5 Torrent Pharma Recent Developments/Updates 7 Insulin API Manufacturing Cost Analysis 7.1 Insulin API Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Insulin API 7.4 Insulin API Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Insulin API Distributors List 8.3 Insulin API Customers 9 Insulin API Market Dynamics 9.1 Insulin API Industry Trends 9.2 Insulin API Growth Drivers 9.3 Insulin API Market Challenges 9.4 Insulin API Market Restraints 10 Global Market Forecast 10.1 Insulin API Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Insulin API by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Insulin API by Type (2022-2027) 10.2 Insulin API Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Insulin API by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Insulin API by Application (2022-2027) 10.3 Insulin API Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Insulin API by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Insulin API by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Insulin API Sales (Kg) Growth Rate Comparison by Type (2021-2027) Table 2. Global Insulin API Sales (Kg) Comparison by Application (2021-2027) Table 3. Global Insulin API Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Insulin API Covered in This Study Table 5. Global Insulin API Sales (Kg) of Key Manufacturers (2016-2021) Table 6. Global Insulin API Sales Share by Manufacturers (2016-2021) Table 7. Global Insulin API Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Insulin API Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Insulin API Average Price (K USD/Kg) of Key Manufacturers (2016-2021) Table 10. Manufacturers Insulin API Manufacturing Sites and Area Served Table 11. Manufacturers Insulin API Product Type Table 12. Global Insulin API Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Insulin API by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin API as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Insulin API Sales by Region (2016-2021) & (Kg) Table 16. Global Insulin API Sales Market Share by Region (2016-2021) Table 17. Global Insulin API Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Insulin API Sales by Country (2016-2021) & (Kg) Table 19. North America Insulin API Sales Market Share by Country (2016-2021) Table 20. North America Insulin API Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Insulin API Revenue Market Share by Country (2016-2021) Table 22. Europe Insulin API Sales by Country (2016-2021) & (Kg) Table 23. Europe Insulin API Sales Market Share by Country (2016-2021) Table 24. Europe Insulin API Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Insulin API Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Insulin API Sales by Region (2016-2021) & (Kg) Table 27. Asia Pacific Insulin API Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Insulin API Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Insulin API Revenue Market Share by Region (2016-2021) Table 30. Latin America Insulin API Sales by Country (2016-2021) & (Kg) Table 31. Latin America Insulin API Sales Market Share by Country (2016-2021) Table 32. Latin America Insulin API Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Insulin API Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Insulin API Sales by Country (2016-2021) & (Kg) Table 35. Middle East and Africa Insulin API Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Insulin API Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Insulin API Revenue Market Share by Country (2016-2021) Table 38. Global Insulin API Sales (Kg) by Type (2016-2021) Table 39. Global Insulin API Sales Market Share by Type (2016-2021) Table 40. Global Insulin API Revenue (Million US$) by Type (2016-2021) Table 41. Global Insulin API Revenue Share by Type (2016-2021) Table 42. Global Insulin API Price (K USD/Kg) by Type (2016-2021) Table 43. Global Insulin API Sales (Kg) by Application (2016-2021) Table 44. Global Insulin API Sales Market Share by Application (2016-2021) Table 45. Global Insulin API Revenue (Million US$) by Application (2016-2021) Table 46. Global Insulin API Revenue Share by Application (2016-2021) Table 47. Global Insulin API Price (K USD/Kg) by Application (2016-2021) Table 48. Novo Nordisk Corporation Information Table 49. Novo Nordisk Description and Business Overview Table 50. Novo Nordisk Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 51. Novo Nordisk Insulin API Product Table 52. Novo Nordisk Recent Developments/Updates Table 53. Sanofi-Aventis Corporation Information Table 54. Sanofi-Aventis Description and Business Overview Table 55. Sanofi-Aventis Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 56. Sanofi-Aventis Insulin API Product Table 57. Sanofi-Aventis Recent Developments/Updates Table 58. Eli Lilly Corporation Information Table 59. Eli Lilly Description and Business Overview Table 60. Eli Lilly Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 61. Eli Lilly Insulin API Product Table 62. Eli Lilly Recent Developments/Updates Table 63. Tonghua Dongbao Corporation Information Table 64. Tonghua Dongbao Description and Business Overview Table 65. Tonghua Dongbao Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 66. Tonghua Dongbao Insulin API Product Table 67. Tonghua Dongbao Recent Developments/Updates Table 68. Ganlee Corporation Information Table 69. Ganlee Description and Business Overview Table 70. Ganlee Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 71. Ganlee Insulin API Product Table 72. Ganlee Recent Developments/Updates Table 73. United Laboratory Corporation Information Table 74. United Laboratory Description and Business Overview Table 75. United Laboratory Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 76. United Laboratory Insulin API Product Table 77. United Laboratory Recent Developments/Updates Table 78. Biocon Corporation Information Table 79. Biocon Description and Business Overview Table 80. Biocon Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 81. Biocon Insulin API Product Table 82. Biocon Recent Developments/Updates Table 83. Amphastar Corporation Information Table 84. Amphastar Description and Business Overview Table 85. Amphastar Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 86. Amphastar Insulin API Product Table 87. Amphastar Recent Developments/Updates Table 88. Wockhardt Corporation Information Table 89. Wockhardt Description and Business Overview Table 90. Wockhardt Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 91. Wockhardt Insulin API Product Table 92. Wockhardt Recent Developments/Updates Table 93. Julphar Diabetes Corporation Information Table 94. Julphar Diabetes Description and Business Overview Table 95. Julphar Diabetes Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 96. Julphar Diabetes Insulin API Product Table 97. Julphar Diabetes Recent Developments/Updates Table 98. Torrent Pharma Corporation Information Table 99. Torrent Pharma Description and Business Overview Table 100. Torrent Pharma Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2016-2021) Table 101. Torrent Pharma Insulin API Product Table 102. Torrent Pharma Recent Developments/Updates Table 103. Production Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Insulin API Distributors List Table 106. Insulin API Customers List Table 107. Insulin API Market Trends Table 108. Insulin API Growth Drivers Table 109. Insulin API Market Restraints Table 110. Global Insulin API Sales Forecast by Type (2022-2027) & (Kg) Table 111. Global Insulin API Sales Market Share Forecast by Type (2022-2027) Table 112. Global Insulin API Revenue Forecast by Type (2022-2027) & (US$ Million) Table 113. Global Insulin API Revenue Market Share Forecast by Type (2022-2027) Table 114. Global Insulin API Sales Forecast by Application (2022-2027) & (Kg) Table 115. Global Insulin API Sales Market Share Forecast by Application (2022-2027) Table 116. Global Insulin API Revenue Forecast by Application (2022-2027) & (US$ Million) Table 117. Global Insulin API Revenue Market Share Forecast by Application (2022-2027) Table 118. Global Insulin API Sales Forecast by Region (2022-2027) & (Kg) Table 119. Global Insulin API Sales Market Share Forecast by Region (2022-2027) Table 120. Global Insulin API Revenue Forecast by Region (2022-2027) & (US$ Million) Table 121. Global Insulin API Revenue Market Share Forecast by Region (2022-2027) Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Insulin API Figure 2. Global Insulin API Market Share by Type in 2020 & 2027 Figure 3. Regular Human Insulin Product Picture Figure 4. Insulin Analogue Product Picture Figure 5. Global Insulin API Market Share by Application in 2020 & 2027 Figure 6. Fast-Acting Figure 7. Premix Figure 8. Long-Acting Figure 9. Global Insulin API Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Insulin API Market Size 2016-2027 (US$ Million) Figure 11. Global Insulin API Sales 2016-2027 (Kg) Figure 12. Global Insulin API Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Insulin API Sales Share by Manufacturers in 2020 Figure 14. Global Insulin API Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Insulin API Players: Market Share by Revenue in 2020 Figure 16. Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Insulin API Sales Market Share by Region (2016-2021) Figure 18. Global Insulin API Sales Market Share by Region in 2020 Figure 19. Global Insulin API Revenue Market Share by Region (2016-2021) Figure 20. Global Insulin API Revenue Market Share by Region in 2020 Figure 21. U.S. Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Insulin API Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Insulin API by Type (2016-2021) Figure 46. Sales Market Share of Insulin API by Application (2016-2021) Figure 47. Sales Market Share of Insulin API by Application in 2020 Figure 48. Revenue Share of Insulin API by Application (2016-2021) Figure 49. Revenue Share of Insulin API by Application in 2020 Figure 50. Manufacturing Cost Structure of Insulin API Figure 51. Manufacturing Process Analysis of Insulin API Figure 52. Insulin API Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Novo Nordisk Sanofi-Aventis Eli Lilly Tonghua Dongbao Ganlee United Laboratory Biocon Amphastar Wockhardt Julphar Diabetes Torrent Pharma